tag womens-health 
Rethinking Clinical Trials
DECEMBER 20, 2023
CVD is the leading cause of mortality in women. Hospital admissions with acute coronary syndrome in women younger than 55 years increased 21% in 1995-1999 and 31% in 2010-2014. The biggest barrier for CV medicine is the lack of women leaders in CV. years for males and 5.5 years for females at age 45 years or older.
XTalks
FEBRUARY 8, 2024
Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rethinking Clinical Trials
OCTOBER 27, 2022
Professor, Department of Population Health Sciences. Health care and the internet are intertwined. Perakslis said his definition of digital health is any time you mix medical information and the internet. There are doable ways to increase cybersecurity in health care. Duke Clinical Research Institute. Andrea Downing.
Rethinking Clinical Trials
AUGUST 23, 2022
Associate Professor, Global Health. We have seen that having a higher proportion of women authors resulted in a higher proportion of women enrolled per trial. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speakers. Gerald Bloomfield, MD, MPH. Associate Professor with Tenure, Medicine. Michelle Kelsey, MD.
Rethinking Clinical Trials
DECEMBER 6, 2022
This study asks how can we better facilitate health behaviors in patients with chronic diseases and can we leverage technology? The trial enrolled 187 patients, with 35% women, 47% African American, 10% Hispanic, age 59 years. Medication adherence can be a barrier to effectiveness. Sites have a lot of trials that are competing.
pharmaphorum
FEBRUARY 26, 2021
Between 1896 and 1897, J&J enabled a huge step forward for women’s health when it manufactured the first mass-produced sanitary protection products. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. The post A history of Johnson & Johnson appeared first on.
The Pharma Data
MAY 4, 2021
down 21%, driven by a negative impact from the COVID-19 pandemic resulting in a decline in patient visits to doctors for preventative health purposes, as well as the loss of patent protection in the U.S. mg) in women with uterine fibroids. mg) in healthy women ages 18-35 who are at risk for pregnancy. Chantix in the U.S.,
Expert insights. Personalized for you.
169 
Let's personalize your content